Catheter Precision (VTAK) has received a purchase order from Centre Hospitalier Universitaire de Rennes. This is the first purchase order from Universite de Rennes and marks the largest purchase order for the VIVO product line to date. CHU Rennes serves almost 500,000 patients annually with a mission of teaching, research and innovation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision forms new joint venture with Chelak iECG called Kardionav
- Catheter Precision’s LockeT Sales Surge in Q2 2025
- 3 Penny Stocks to Watch Now, 6/12/25
- Catheter Precision announces Q2 sales on track to be highest to date
- Catheter Precision Stock (VTAK) Rockets 170% on a Delayed Investor Reaction